U.S. Court of Appeals for the Ninth Circuit, 2016

Harris v. Amgen, Inc.

Harris v. Amgen, Inc.
U.S. Court of Appeals for the Ninth Circuit · Decided March 28, 2016 · Farris, Fletcher, Korman
646 F. App'x 531

Counsel

Stephen J. Fearon, Jr., Squitteri & Fearon, LLP, New York, NY, Francis M. Gregorek, Betsy C. Manifold, Rachele R. Rickert, Wolf Haldenstein Adler Freeman & Herz LLP, San Diego, CA, Daniel L. Keller, Esquire, Keller, Fishback & Jackson, LLP, Tarzana, CA, Thomas James McKenna, Esquire, Gainey McKenna & Egleston, New York, NY, Mark C. Rifkin, Wolf Haldenstein Adler Freeman & Herz LLP, New York, NY, for Plaintiffs-Appellants., Emily Seymour Costin, Jonathan Rose, Alston & Bird LLP, Washington, DC, Steven Oliver Kramer, Esquire, Mayer Brown LLP, Los Angeles, CA, Jonathan David Moss, Sheppard Mullin Richter & Hamp■ton LLP, Los Angeles, CA, Moez Kaba, Steven Feldman, Esquire, Hueston Henni-gan LLP, Los Angeles, Ca, Glenn Vanzu-ra, Bruce Adam Wessel, Irell & Manella LLP, Los Angeles, CA, Daniel Volchok, Seth P. Waxman, Wilmer Cutler Pickering Hale and Dorr LLP, Washington, DC, Russell Laurence Hirsehhorn, Esquire, Myron D. Rumeld, Esquire, Proskauer Rose LLP, New York, NY, for Defendants-Appellees.

Harris v. Amgen, Inc.

Opinion of the Court

ORDER

This case is remanded to the district court for further proceedings consistent with the decision of the United States Supreme Court in Amgen Inc. v. Harris, — U.S.-, 136 S.Ct. 768, 193 L.Ed.2d 696 (2016).

REMANDED.

Case-law data current through December 31, 2025. Source: CourtListener bulk data.